FDA announces recall of Ga. compounder's sterile products

03/22/2013 | Reuters

Clinical Specialties Compounding recalled all the sterile products it has distributed in the country since Oct. 19, and the FDA warned health care providers following reports of serious eye infections tied to injections of the cancer treatment Avastin that had been prepared by the Georgia pharmacy. The FDA said the recall was extended to all of the company's other sterile products due to concerns about a lack of sterility assurance and covers dozens of treatments, including many eye treatments and antibiotics.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC